Age, Biography and Wiki

Beth Overmoyer was born on 1960, is a physician. Discover Beth Overmoyer's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is She in this year and how She spends money? Also learn how She earned most of networth at the age of 63 years old?

Popular As N/A
Occupation N/A
Age 63 years old
Zodiac Sign
Born 1960
Birthday 1960
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on 1960. She is a member of famous physician with the age 63 years old group.

Beth Overmoyer Height, Weight & Measurements

At 63 years old, Beth Overmoyer height not available right now. We will update Beth Overmoyer's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.

Family
Parents Not Available
Husband Not Available
Sibling Not Available
Children Not Available

Beth Overmoyer Net Worth

Her net worth has been growing significantly in 2022-2023. So, how much is Beth Overmoyer worth at the age of 63 years old? Beth Overmoyer’s income source is mostly from being a successful physician. She is from . We have estimated Beth Overmoyer's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income physician

Beth Overmoyer Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2007

In 2007, Overmoyer moved to the Dana–Farber Cancer Institute, where she established the Inflammatory Breast Cancer Program in 2009. Inflammatory breast cancer is a rare, fast-growing disease, which causes the lymph vessels within breast skins to become clogged with tumor cells. Overmoyer established the Inflammatory Breast Cancer Registry, a repository of information and tumor samples to aid with the understanding and diagnosis of the disease. She showed that Ruxolitinib was capable of suppressing the inflammatory breast cancer pathway in patients with triple-negative breast cancer.

1960

Beth Ann Overmoyer (born 1960) is an American physician and oncologist. She is Director of the Inflammatory Breast Cancer Program at the Dana–Farber Cancer Institute.